Seeding Collaborations for Translational Research to Discover and Develop New Therapies for Diseases and Conditions within NIDDK's Mission (Revisions) (R01) -- This opportunity has been expired

Funding Agency:
National Institutes of Health

The purpose of this funding opportunity announcement (FOA) is to seed collaborations that enable translational research for the discovery and development of therapies for diseases and conditions of interest to NIDDK.  The FOA encourages collaborations through revisions to active NIDDK R01 research project grants.  The revision allows the Program Director/Principal Investigator (PD/PI) to propose an expansion of the specific aims to develop collaborations and approaches that facilitate translational research on target identification, early-stage pharmacological validation of targets and pre-therapeutic leads, lead optimization, and limited pre-clinical development.


  • Letter of Intent Due Date(s): 30 days prior to Application Due Date
  • R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
  • AIDS Due Dates: Jan. 7, May 7, Sep. 7

PAR-14-006 Expiration Date New Date March 8, 2016 per issuance of NOT-DK-16-010. (Original Expiration Date: January 8, 2017)

Agency Website

Eligibility Requirements

The parent project must be an active NIDDK R01 research project.  The project period of the revision application may not extend beyond that of the parent award.  Grants that are in a no-cost extension period will not be considered for support under this program.

All revision applications must be submitted by the same PD/PI (or Contact PD/PI for multi-PI grants) as listed on the current award.



Amount Description

Application budgets are limited to $75,000 direct costs per year, but need to reflect the actual needs of the proposed project.

The total project period for an application submitted in response to this FOA may not exceed two years. Applicants may request support for up to 2 years, but activities proposed must be completed by the end of the parent grant award period.

Funding Type





Medical - Translational

External Deadline

March 7, 2016